stars 1 stars 2 stars 3

Prolynx is a biotechnology company dedicated to developing ultra-long-acting medicines for obesity and other metabolic diseases. We are advancing a proprietary portfolio of extended-duration therapeutic candidates targeting once-monthly and once-quarterly dosing, with the potential to smooth the PK peaks and troughs that can contribute to tolerability issues and to support more consistent, long-term treatment.

Prolynx Questions

Chris Boulton is the CEO of Prolynx.

21 people are employed at Prolynx.

Prolynx is based in San Francisco, California.

Top Prolynx Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users